Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell CarcinomaDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasmRecruitingPhase 22026-05-20NCT07205731

3 results · Page 1 of 1

Swipe the table sideways for more columns.

30 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre François BaclesseCaenFrance39
Centre Hospitalier Annecy GenevoisAnnecyFrance1
Centre Hospitalier de la Côte BasqueBayonneFrance11
Centre Hospitalier de PerpignanPerpignanFrance3
Centre Léon BERARD de LyonLyonFrance1
Centre Régional du Lutte Contre Le Cancer - Institut GodinotReimsFrance1
CH Béthune et BeuvryBeuvryFrance1
CHRU BrestBrestFrance21
CHRU LilleLilleFrance32
CHRU ToursToursFrance18
CHU AmiensAmiensFrance49
CHU BesançonBesançonFrance32
CHU Clermont-FerrandClermont-FerrandFrance62
CHU de ReimsReimsFrance24
CHU DijonDijonFrance37
CHU LimogesLimogesFrance42
CHU NancyNancyFrance24
CHU PoitiersPoitiersFrance70
CHU RennesRennesFrance57
CHU RouenRouenFrance49
Groupe Hospitalier MutualisteGrenobleFrance4
Groupe Hospitalier Rance EmeraudeSt-MaloFrance4
Hôpital Européen Georges-PompidouParisFrance6
Hôpital Saint-Louis LariboisièreParisFrance1
ICHF Centre Pierre CurieBeuvryFrance1